These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17016062)

  • 1. New evidence of H1-receptor independent COX-2 inhibition by fexofenadine HCl in vitro.
    Juergens UR; Gillissen A; Uen S; Racké K; Stöber M; Darlath W; Vetter H
    Pharmacology; 2006; 78(3):129-35. PubMed ID: 17016062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of fexofenadine on arachidonic acid metabolism in cultured human monocytes.
    Juergens UR; Darlath W; Stober M; Racké K; Tasci S; Gillissen A; Vetter H
    Pharmacology; 2006; 76(1):40-5. PubMed ID: 16254456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro.
    Asano K; Kanai KI; Suzaki H
    Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive activity of fexofenadine hydrochloride on thymus- and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro.
    Asano K; Kanai K; Suzaki H
    Int Arch Allergy Immunol; 2004 Mar; 133(3):267-75. PubMed ID: 14976396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
    Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo.
    Asano K; Kanai K; Furuta A; Furuya A; Suzaki H; Hisamitsu T
    J Pharm Pharmacol; 2007 Oct; 59(10):1389-95. PubMed ID: 17910814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
    Waterbury LD; Silliman D; Jolas T
    Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride.
    Nogaki T; Asano K; Furuta A; Kanai K; Suzaki I; Kanei A; Suzaki H
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):139-45. PubMed ID: 22830293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
    Pichat P; Angel I; Arbilla S
    Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro.
    Asano K; Kanai K; Suzaki H
    Arzneimittelforschung; 2004; 54(8):436-43. PubMed ID: 15460210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
    Gelfand EW; Appajosyula S; Meeves S
    Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
    Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
    Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.
    Nandi J; Das PK; Zinkievich JM; Baltodano JD; Levine RA
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):127-34. PubMed ID: 18759857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.